Skip to main content

Table 1 Clinical features and treatment outcomes of four cases of aHUS

From: Clinical features and outcomes of four atypical hemolytic uremic syndrome cases at a single institution in Miyazaki Prefecture from 2015 to 2019

 

Case 1

Case 2

Case 3

Case 4

Age

59 years

57 years

74 years

67 years

Sex

Female

Female

Male

Female

Underlying disease

Chronic kidney disease

Hypertension

Hypertension

Hypertension, chronic kidney disease

Initial symptoms/clinical manifestation

Pulmonary hemorrhage

Microangiopathic hemolytic anemia Thrombocytopenia

Renal dysfunction

Pulmonary hemorrhage

Microangiopathic hemolytic anemia Thrombocytopenia

Renal dysfunction

Pulmonary hemorrhage

Microangiopathic hemolytic anemia Thrombocytopenia

Renal dysfunction

Microangiopathic hemolytic anemia Thrombocytopenia

Liver dysfunction

Renal dysfunction

Urine occult blood

++

+

+++

++

WBC (× 109/L)

12.2

10.2

14.0

8.5

Hb (g/dL)

8.3

7.9

9.3

8.0

Plt (× 109/L)

96

17

59

20

LDH (U/L)

474

2651

1972

2663

Cr (mg/dL)

2.3

1.8

4.77

5.57

ADAMTS 13 activity (%) /inhibitor (BU/ml)

48.8%/–

65.4%/–

59.8%/–

67.2%/–

Histological findings

The swelling of endothelial cells without intravascular thrombosis in kidney

Ulcer lesions with intravascular thrombosis in intestine

not examined

not examined

Diagnosis of aHUS

Day 16 after renal transplantation

Day 7 after admission

Day 4 after admission

Day 1 after admission

Trigger

Renal transplantation

Influenza/acute interstitial pneumonia (AIP)/disseminated intravascular coagulation (DIC)

Influenza-mimicking symptoms/AIP/DIC

Severe fever with thrombocytopenia syndrome

Treatment

Plasma exchange, prednisolone

Plasma exchange, prednisolone

Plasma exchange, prednisolone, eculizumab

Plasma exchange, prednisolone, eculizumab

Treatment response

Transient response → progressive disease

Complete remission

Partial remission (CBC, LDH, renal dysfunction)

Progressive disease (Lung)

Complete remission

Side effect

–

–

–

–

Outcome

Dead (34 days)

Alive (768 days)

Dead (13 days)

Alive (235 days)

Genetic mutation

–

–

–

–

Genetic variants

CFH (H402Y, E936D), THBD (A473V)

CFH (V62I, H402Y, V837I)

CFH (H402Y, E936D), THBD(A473V)

CFH (V62I, H402Y,E936D), THBD (A473V)